Conéctate
Conéctate
O Conectarse con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Regístrate
O Conectarse con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PROTAGONIST THERAPEUTICS, INC.

(PTGX)
  Reporte
Diferido Nasdaq  -  22:00 26/09/2022
8.200 USD   -1.44%
25/08Protagonist Therapeutics, Inc. : JMP Securities mantiene su recomendación de compra
MM
04/08Protagonist Therapeutics, Inc. informa de los resultados del segundo trimestre y de los seis meses finalizados el 30 de junio de 2022
CI
26/05Protagonist Therapeutics, Inc. presentará en ASCO 2022 los resultados clínicos actualizados de la fase 2 de la rusfertida en la policitemia vera (PV)
CI
ResumenCotizacionesGráficosNoticiasRatingsAgendaEmpresaFinanzasConsensoRevisionesDerivadosFondos 
ResumenTodasRecomendaciones analistasOtros idiomasComunicadosPubls. oficialesNoticias del sector
Noticias en otros idiomas sobre PROTAGONIST THERAPEUTICS, INC.
20/09Protagonist Therapeutics Reports Granting of Inducement Award
05/08Protagonist Therapeutics : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q)
05/08Protagonist Therapeutics : Q2 Earnings Snapshot
04/08PROTAGONIST THERAPEUTICS, INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
04/08Protagonist Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six ..
04/08Protagonist Therapeutics : Reports Second Quarter 2022 Financial Results and Provides Corp..
19/07Protagonist Therapeutics Reports Granting of Inducement Award
24/06Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) added..
24/06Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) dropp..
24/06Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) added..
24/06Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) dropp..
24/06Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) dropp..
24/06Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) added..
24/06Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) added..
24/06Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) dropp..
24/06Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) added..
24/06Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) dropp..
24/06Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) added..
24/06Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) dropp..
02/06Protagonist Therapeutics, Inc : Submission of Matters to a Vote of Security Holders (form ..
01/06Protagonist Therapeutics to Participate at the Jefferies Healthcare Conference
26/05Protagonist Therapeutics, Inc. to Present Updated Phase 2 Rusfertide Clinical Results i..
05/05PROTAGONIST THERAPEUTICS, INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
04/05Protagonist Therapeutics : Q1 Earnings Snapshot
04/05Protagonist Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended Mar..
26/04Protagonist Therapeutics' Shares Plummet After Reporting Trial Data for Inflammatory Bo..
26/04Top Midday Decliners
26/04Top Premarket Decliners
26/04Protagonist Therapeutics : Announces Topline Data from Phase 2 IDEAL Study of PN-943 in Ul..
26/04Protagonist Therapeutics, Inc : Financial Statements and Exhibits (form 8-K)
26/04Transcript : Protagonist Therapeutics, Inc. - Special Call
25/04Protagonist Therapeutics Announces Topline Data from Phase 2 IDEAL Study of PN-943 in U..
25/04Protagonist Therapeutics Announces Topline Data from Phase 2 IDEAL Study of PN-943 in U..
20/04Protagonist Therapeutics : Initial Statement of Beneficial Ownership (Form 3)
19/04Protagonist Therapeutics Reports Granting of Inducement Awards
14/04Sector Update: Health Care Stocks Fading Late, Stop Just Shy of Higher Clo..
14/04Top Midday Decliners
14/04Protagonist Stock Tumbles Thursday as FDA Plans to Rescind Rusfertide Breakthrough Desi..
14/04Sector Update: Health Care Stocks Edging Lower on Thursday
14/04Sector Update: Health Care
14/04Wall Street Treads Water Pre-Bell; Jobless Claims Rise
14/04Sector Update: Health Care Stocks Lean Lower Premarket Thursday
14/04Sector Update: Health Care
14/04Top Premarket Decliners
14/04Protagonist Therapeutics Gets FDA Letter to Rescind Breakthrough Therapy Designation fo..
14/04Protagonist Shares Tumble After FDA Says It May Pull Rusfertide Breakthrough Designatio..
13/04Protagonist Therapeutics Gets FDA Letter to Rescind Breakthrough Therapy Designation fo..
13/04Protagonist Therapeutics, Inc : Other Events, Financial Statements and Exhibits (form 8-K)
13/04Protagonist Therapeutics, Inc. Expects to Announce Top-Line Data from Its Phase 2 Clini..
31/03Protagonist Therapeutics, Inc : Change in Directors or Principal Officers (form 8-K)
28/03Protagonist Therapeutics Names Asif Ali Finance Chief
28/03Protagonist Therapeutics Announces Appointment of Asif Ali as Executive Vice President ..
28/03Protagonist Therapeutics Announces Appointment of Asif Ali as Executive Vice President ..
23/03Protagonist Therapeutics, Inc : Change in Directors or Principal Officers (form 8-K)
23/03Protagonist Therapeutics, Inc. Announces Resignation of Don Kalkofen as Principal Finan..
23/03Protagonist Therapeutics, Inc. Announces Resignation of Don Kalkofen, Chief Financial O..
16/03Protagonist Therapeutics Gets $25 Million Milestone Payment from J&J's Janssen Biotech
16/03Protagonist Therapeutics Earns $25 Million Milestone Payment from Janssen Biotech for D..
01/03PROTAGONIST THERAPEUTICS, INC Management's Discussion and Analysis of Financial Condit..
01/03Protagonist Therapeutics : Reports Fourth Quarter and Full Year 2021 Financial Results and..
28/02Protagonist Therapeutics : Q4 Earnings Snapshot
28/02Protagonist Therapeutics, Inc. Reports Earnings Results for the Full Year Ended Decembe..
28/02Protagonist Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended De..
28/02Protagonist Therapeutics, Inc. Announces Pivotal Phase 3 VERIFY Study of Rusfertide in ..
22/02Protagonist Therapeutics, Inc : Change in Directors or Principal Officers (form 8-K)
10/02Protagonist Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Co..
11/01Transcript : Protagonist Therapeutics, Inc. Presents at JPMorgan 40th Annual ..
04/01/C O R R E C T I O N -- Protagonist Therapeutics, Inc./
2021Insider Sell: Protagonist Therapeutics
2021Protagonist Therapeutics Presents Updated Phase 2 Rusfertide Data
2021Protagonist Therapeutics to Present at the JMP Securities Hematology and Oncology Summi..
2021Protagonist Therapeutics Picks PN-235 for Mid-Stage Trials in Multiple Indications
2021Protagonist Therapeutics Announces the Selection of Oral Peptide PN-235 into Phase 2 Cl..
2021Protagonist Therapeutics Announces Selection of Oral Peptide PN-235 into Phase 2 Clinic..
2021Protagonist Therapeutics Announces Positive Phase 2a Data Supporting the Potential Use ..
2021Protagonist Therapeutics Announces 'Positive Data' for Rusfertide as Possible Hereditar..
2021Protagonist Therapeutics, Inc. Announces Positive Phase 2A Data Supporting the Potentia..
2021Protagonist Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences
2021Protagonist Therapeutics Announces Updated Data from Phase 2 Study of Rusfertide in Pol..
2021Protagonist Therapeutics : Q3 Earnings Snapshot
2021PROTAGONIST THERAPEUTICS, INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
2021Protagonist Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corp..
2021Protagonist Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine ..
2021Protagonist Therapeutics Gets $7.5 Million Milestone Payment from Johnson & Johnson's J..
2021Protagonist Therapeutics Earns $7.5 Million Milestone Payment from IL-23 Receptor Colla..
2021Protagonist Therapeutics Earns $7.5 Million Milestone Payment from IL-23 Receptor Colla..
2021North American Morning Briefing : Stock Futures -3-
2021Top Midday Decliners
2021Protagonist Therapeutics : Shares Drop on Elevated Volume
2021It's just a period of market normalization
2021Protagonist Therapeutics : to Present at the Jefferies Next Generation IBD Therapeutics Su..
2021Analyst recommendations: Cigna, Halliburton, Nike, Nio, Trex...
2021Health Care Stocks Sliding in Late Monday Trading
2021Health Care Stocks Drifting Monday as Biotechs Climb
2021Top Midday Gainers
2021Health Care Stocks Trade Lower Premarket Monday
2021Wall Street Declines on Soaring Energy Prices
2021Protagonist Therapeutics : Health Care
2021Protagonist Therapeutics : Says FDA Lifts Clinical Hold on Rusf..
2021Top Premarket Gainers
Próximo evento sobre PROTAGONIST THERAPEUTICS, INC.